09May 2026
SEMAGLUTIDE GENERICS EXPAND INDIA’S GLP-1 DRUG MARKET
SEMAGLUTIDE GENERICS EXPAND INDIA’S GLP-1 DRUG MARKET Why in the News? The launch of generic versions of semaglutide has led to a 75% rise in sales of GLP-1 drugs in India within one month. Sales volume of semaglutide increased from 25,000 units in February to 1.7 lakh units in April 2026 after patent expiry of …
Read More
